Private equity proponents argue that one of the asset class’s biggest selling points is its low volatility compared with ...

One of the testiest exchanges at a company conference call in recent years took place during the fourth-quarter 2024 results ...

Biopharma and life sciences hedge funds enjoyed mixed success in June.Several posted strong results and are currently in the black for the year. However, most remain solidly in the red heading ...

The lawyer behind a lawsuit brought against LSV Asset Management hopes a victory in court will benefit not only the ...

For years, immigration, federal stimulus, and a strong technology sector have driven U.S. growth. But with these tailwinds ...

Glenview Capital Management was up more than 4 percent in the second quarter, thanks in large part to a strong 4.34 percent gain in June, according to the HSBC hedge fund database.Even so, the ...